Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Quote

Not a forecast

“These authors demonstrated that psilocybin may offer hope for human depression at the end of life, and I look forward to the phase III trial.”
· "No formal assessment of blinding integrity...was conducted" Psychedelic Research Can't Go Back in Time, Can It? · substack post Paid

Closing of the same review. Psilocybin cut HADS depression more than niacin placebo at 6-7 weeks (d = 1.12), but the crossover-only comparison showed no difference. The author says psilocybin may help end-of-life depression and expects a phase III trial.

Descriptive, retrospective, or a statement of preference; no future state asserted.